Biodesix, Inc. (BDSX)
Last updated: 2026-10-23 13:08:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Biodesix, Inc. (BDSX) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $23.93, with a market capitalization of $252.49M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.26 to $31.97. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$252.49M | |
$23.76 | |
$639.80 | |
$3.44 | |
$23.93 | |
134.16K | |
101.44K | |
-- | |
$31.97 | |
$5.26 | |
-- | |
-- |
Biodesix, Inc. (BDSX) Pre-Market Stock Price
Biodesix, Inc. (BDSX) is trading at $23.95 in pre-market trading as of 2026-10-22 23:31:00, up 0.08% ($0.02) from the previous close of $23.93
Pre-market trading shows how investors are pricing BDSX before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Biodesix, Inc. (BDSX) 7-Day Stock Price Change
Over the past seven days, Biodesix, Inc. (BDSX) moved from $23.99 to $23.93, representing a decline of 0.24% ($0.06).
The stock traded between $22.60 and $25.24 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 70.49 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
BDSX 52-Week Price Position
Position in Range: 69.9%
BDSX is currently trading at $23.93, placing it 69.9% of the way from its 52-week low of $5.26 to its 52-week high of $31.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Biodesix, Inc. (BDSX)?
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Biodesix, Inc. Information
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 334 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Biodesix, Inc. (BDSX) Stock on MEXC
Eligible investors can buy real shares of Biodesix, Inc. (BDSX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Biodesix, Inc. (BDSX) stock price today?
2.Is BDSX stock going up or down today?
3.What is BDSX pre-market price?
4.What is BDSX after-hours price?
5.Is BDSX stock trading now?
6.Where does BDSX sit relative to its 52-week high and low?
7.What sector is Biodesix, Inc. in?
8.What is Biodesix, Inc.'s market capitalization and where is it listed?
9.How is BDSX valued in terms of P/E ratio and EPS?
10.Does Biodesix, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
BDSX Stock Calculator
Estimate the value between BDSX shares and USD.
BDSX Shares to USD
1.00 BDSX shares = 23.932 USD
Calculations are estimates based on the latest available price and are for reference only.



